Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who has pulmonary hypertension treated with inhaled iloprost older than 18 years old.
Primary (idiopathic and familial) pulmonary hypertension (PH) with New York Heart Association (NYHA) functional class and exercise capacity, defined as class III and IV.
Pulmonary arterial hypertension (PAH) due to scleroderma with New York Heart Association (NYHA) functional class and exercise capacity, defined as class III and IV.
Patients who signed written informed consent.
You may not be if
Severe coronary heart disease or unstable angina; Myocardial infarction within the last six months; Decompensated cardiac failure if not under close medical supervision;
Severe arrhythmias;
Cerebrovascular events (e.g. transient ischaemic attack, stroke) within the last 3 months.
Pulmonary hypertension due to venous occlusive disease.
Congenital or acquired valvular defects with clinically relevant myocardial function disorders not related to pulmonary hypertension.